位置:首页 > 蛋白库 > 5NTC_XENTR
5NTC_XENTR
ID   5NTC_XENTR              Reviewed;         568 AA.
AC   Q5EBF1;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   03-AUG-2022, entry version 82.
DE   RecName: Full=Cytosolic purine 5'-nucleotidase {ECO:0000250|UniProtKB:P49902};
DE            EC=3.1.3.5 {ECO:0000250|UniProtKB:P49902};
DE            EC=3.1.3.99 {ECO:0000250|UniProtKB:P49902};
DE   AltName: Full=Cytosolic nucleoside phosphotransferase 5'N {ECO:0000250|UniProtKB:P49902};
DE            EC=2.7.1.77 {ECO:0000250|UniProtKB:P49902};
GN   Name=nt5c2;
OS   Xenopus tropicalis (Western clawed frog) (Silurana tropicalis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Silurana.
OX   NCBI_TaxID=8364;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Broad specificity cytosolic 5'-nucleotidase that catalyzes
CC       the dephosphorylation of 6-hydroxypurine nucleoside 5'-monophosphates.
CC       In addition, possesses a phosphotransferase activity by which it can
CC       transfer a phosphate from a donor nucleoside monophosphate to an
CC       acceptor nucleoside, preferably inosine, deoxyinosine and guanosine.
CC       Has the highest activities for IMP and GMP followed by dIMP, dGMP and
CC       XMP. Could also catalyze the transfer of phosphates from pyrimidine
CC       monophosphates but with lower efficiency. Through these activities
CC       regulates the purine nucleoside/nucleotide pools within the cell.
CC       {ECO:0000250|UniProtKB:P49902}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ribonucleoside 5'-phosphate + H2O = a ribonucleoside +
CC         phosphate; Xref=Rhea:RHEA:12484, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:18254, ChEBI:CHEBI:43474, ChEBI:CHEBI:58043; EC=3.1.3.5;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12485;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside + a ribonucleoside 5'-phosphate = a
CC         2'-deoxyribonucleoside 5'-phosphate + a ribonucleoside;
CC         Xref=Rhea:RHEA:19961, ChEBI:CHEBI:18254, ChEBI:CHEBI:18274,
CC         ChEBI:CHEBI:58043, ChEBI:CHEBI:65317; EC=2.7.1.77;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + IMP = inosine + phosphate; Xref=Rhea:RHEA:27718,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:17596, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58053; EC=3.1.3.99;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27719;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GMP + H2O = guanosine + phosphate; Xref=Rhea:RHEA:27714,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16750, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58115; Evidence={ECO:0000250|UniProtKB:D3ZMY7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27715;
CC         Evidence={ECO:0000250|UniProtKB:D3ZMY7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dIMP + H2O = 2'-deoxyinosine + phosphate;
CC         Xref=Rhea:RHEA:29383, ChEBI:CHEBI:15377, ChEBI:CHEBI:28997,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:61194;
CC         Evidence={ECO:0000250|UniProtKB:D3ZMY7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29384;
CC         Evidence={ECO:0000250|UniProtKB:D3ZMY7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dGMP + H2O = 2'-deoxyguanosine + phosphate;
CC         Xref=Rhea:RHEA:29379, ChEBI:CHEBI:15377, ChEBI:CHEBI:17172,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57673;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29380;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + XMP = phosphate + xanthosine; Xref=Rhea:RHEA:28530,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:18107, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57464; Evidence={ECO:0000250|UniProtKB:D3ZMY7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:28531;
CC         Evidence={ECO:0000250|UniProtKB:D3ZMY7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GMP + inosine = guanosine + IMP; Xref=Rhea:RHEA:69584,
CC         ChEBI:CHEBI:16750, ChEBI:CHEBI:17596, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:58115; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dGMP + inosine = 2'-deoxyguanosine + IMP;
CC         Xref=Rhea:RHEA:69580, ChEBI:CHEBI:17172, ChEBI:CHEBI:17596,
CC         ChEBI:CHEBI:57673, ChEBI:CHEBI:58053;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dIMP + inosine = 2'-deoxyinosine + IMP; Xref=Rhea:RHEA:69572,
CC         ChEBI:CHEBI:17596, ChEBI:CHEBI:28997, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:61194; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=inosine + UMP = IMP + uridine; Xref=Rhea:RHEA:69588,
CC         ChEBI:CHEBI:16704, ChEBI:CHEBI:17596, ChEBI:CHEBI:57865,
CC         ChEBI:CHEBI:58053; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=CMP + inosine = cytidine + IMP; Xref=Rhea:RHEA:69592,
CC         ChEBI:CHEBI:17562, ChEBI:CHEBI:17596, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:60377; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=AMP + inosine = adenosine + IMP; Xref=Rhea:RHEA:69596,
CC         ChEBI:CHEBI:16335, ChEBI:CHEBI:17596, ChEBI:CHEBI:58053,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P49902};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P49902};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:P49902};
CC   -!- ACTIVITY REGULATION: Allosterically activated by various compounds
CC       including ATP, 2,3-BPG/2,3-Bisphosphoglyceric acid and Ap4A/P1,P4-
CC       bis(5'-adenosyl) tetraphosphate. Binding of an allosteric activator is
CC       a prerequisiste to magnesium and substrate binding. Inhibited by
CC       inorganic phosphate. {ECO:0000250|UniProtKB:P49902}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:P49902}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P49902}.
CC   -!- SIMILARITY: Belongs to the 5'(3')-deoxyribonucleotidase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC089713; AAH89713.1; -; mRNA.
DR   RefSeq; NP_001015773.1; NM_001015773.1.
DR   AlphaFoldDB; Q5EBF1; -.
DR   SMR; Q5EBF1; -.
DR   DNASU; 548490; -.
DR   GeneID; 548490; -.
DR   KEGG; xtr:548490; -.
DR   CTD; 22978; -.
DR   Xenbase; XB-GENE-988875; nt5c2.
DR   eggNOG; KOG2469; Eukaryota.
DR   InParanoid; Q5EBF1; -.
DR   OrthoDB; 712212at2759; -.
DR   Reactome; R-XTR-2161541; Abacavir metabolism.
DR   Reactome; R-XTR-74259; Purine catabolism.
DR   Proteomes; UP000008143; Chromosome 7.
DR   Proteomes; UP000790000; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0008253; F:5'-nucleotidase activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0050484; F:GMP 5'-nucleotidase activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0050483; F:IMP 5'-nucleotidase activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050146; F:nucleoside phosphotransferase activity; ISS:UniProtKB.
DR   GO; GO:0106411; F:XMP 5'-nucleosidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046085; P:adenosine metabolic process; IBA:GO_Central.
DR   GO; GO:0046054; P:dGMP metabolic process; ISS:UniProtKB.
DR   GO; GO:0046037; P:GMP metabolic process; ISS:UniProtKB.
DR   GO; GO:0046040; P:IMP metabolic process; ISS:UniProtKB.
DR   Gene3D; 3.40.50.1000; -; 2.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR008380; HAD-SF_hydro_IG_5-nucl.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR016695; Pur_nucleotidase.
DR   PANTHER; PTHR12103; PTHR12103; 1.
DR   Pfam; PF05761; 5_nucleotid; 1.
DR   PIRSF; PIRSF017434; Purine_5'-nucleotidase; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR02244; HAD-IG-Ncltidse; 1.
PE   2: Evidence at transcript level;
KW   Allosteric enzyme; ATP-binding; Cytoplasm; Hydrolase; Magnesium;
KW   Metal-binding; Nucleotide metabolism; Nucleotide-binding;
KW   Reference proteome; Transferase.
FT   CHAIN           1..568
FT                   /note="Cytosolic purine 5'-nucleotidase"
FT                   /id="PRO_0000310268"
FT   REGION          528..568
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          548..568
FT                   /note="Required for tetramer assembly"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   COMPBIAS        548..568
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        52
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   ACT_SITE        54
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         52
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         52
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         54
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         54
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         144
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         154
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         202
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         206
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         215
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         249
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         250
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         251
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         292
FT                   /ligand="IMP"
FT                   /ligand_id="ChEBI:CHEBI:58053"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         351
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         453
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
FT   BINDING         456
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P49902"
SQ   SEQUENCE   568 AA;  65965 MW;  E5FB912D35AD64DD CRC64;
     MTTSWSDRLQ NAADLPANMD GHALKKYRRE AYHRVFVNRS LAMEKIKCFG FDMDYTLAVY
     KSPEYESLGF DLTVERLVSI GYPQELLNFV YDPTFPTRGL VFDSTYGNLL KVDAYGNILV
     CAHGFNFMRG PEIREQYPNK FIQRDDTDRF YILNTLFNLP ETYLLACLVD FFTNCDRYTS
     CEMGFKDGDL FMSFRSMFQD VRDAVDWVHY KGSLKEKTVE NLPKYVVKDP KLPLLLSRMN
     EVGKVFLVTN SDYKYTHKIM TYLFDLPHGP KPGSSHRLWQ TYFDLILVDA RKPLFFGEGT
     VLRQVDTNTG KLKIGTYTGP LQHGIVYSGG SSDIVCDLLG AKGKDILYIG DHIFGDILKS
     KKRQGWRTFL VIPELAQELH VWTDKSSLFE ELQSLDIFLA ELYKHLDSSS NERPDISSIQ
     RRIKKVTHDM DMCYGMMGSL FRSGSRQTLF ASQVMRYADL YAASFINLLY YPFSYLFRAA
     HVLMPHESTV EHTHVDIHET ESPMATRNRC SLDFKDSDFK RHQLTRSISE IKPPNLFPQK
     PQEITHCHDE DDDEEEEEEE EEEEEEEE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025